Translation of "Conformité des actifs aux exigences de l'an 2000 " (French → English) :

29. Believes that incentives associated with securitisation need to be adequately addressed; emphasises that solvency and liquidity requirements for securitisations should promote a high-quality and well-diversified investment portfolio, thereby avoiding herding; invites the Commission to examine the securitisation market, including a review of covered bonds which can increase risks on banks’ balance sheets; invites the Commission to propose steps to notably increase its transparency; calls on the Commission to update, where necessary, the current regulation to make it consistent with the new BCBS securitisation framework currently under discussion, at the latest by the beginning of 2013 ...[+++]; proposes imposing a limit on the number of times a financial product can be securitised, and particular requirements for suppliers of securitisation (e.g. originators or sponsors) to retain part of the risks associated with securitisation, thus ensuring that retention of the risks really is being retained by the supplier rather than being passed on to the asset manager, alongside measures to achieve transparency; calls in particular for the introduction of a consistent methodology to value the underlying assets and standardisation of securitisation products across different legislations and jurisdictions;

29. Believes that incentives associated with securitisation need to be adequately addressed; emphasises that solvency and liquidity requirements for securitisations should promote a high-quality and well-diversified investment portfolio, thereby avoiding herding; invites the Commission to examine the securitisation market, including a review of covered bonds which can increase risks on banks’ balance sheets; invites the Commission to propose steps to notably increase its transparency; calls on the Commission to update, where necessary, the current regulation to make it consistent with the new BCBS securitisation framework currently under discussion, at the latest by the beginning of 2013 ...[+++]; proposes imposing a limit on the number of times a financial product can be securitised, and particular requirements for suppliers of securitisation (e.g. originators or sponsors) to retain part of the risks associated with securitisation, thus ensuring that retention of the risks really is being retained by the supplier rather than being passed on to the asset manager, alongside measures to achieve transparency; calls in particular for the introduction of a consistent methodology to value the underlying assets and standardisation of securitisation products across different legislations and jurisdictions;

3. Commends the setting up of an information exchange mechanism on energy agreements between Member States and third countries in order to strive for consistent external actions in the field of energy and to raise the transparency of energy imports into the EU; notes that many agreements in the energy field have investment components – this is the reason why the Commission should ensure that there is coherence between energy agreements and investment agreements, and in particular, that the powers and recommendations of the European P ...[+++]arliament are taken into account in future investment policy; stresses that the Commission must play an active, promoting role when coordinating intergovernmental agreements, so as to ensure that all established entitlements can be realised; before signing energy agreements, the Member States shall submit these negotiated intergovernmental agreements for approval to the Commission, which shall ensure that such agreements are compatible with Union law and, in particular, with the trade and investment rules and the internal energy market, as well as the long-term energy and climate policy targets of the Union;

We will also be monitoring progress made by manufacturers to make their devices year 2000 compliant and will be making available to users information on the year 2000 status of medical devices.

It should be no surprise that getting an active ingredient commercialized globally runs about $200 million, to meet these new and, I would argue, proper, demands for safety.

These non-compliance disclosures to law enforcement, as I said, have to be limited to the serious situations that could be an indication of criminal non-compliance according to FINTRAC.